Knm. Khan et al., PATHOLOGY OF PERBUTYLATED-N-BUTYL-1-DEOXYNOJIROMYCIN - (AN ALPHA-GLUCOSIDASE-1 INHIBITOR) IN SPRAGUE-DAWLEY RATS, Toxicologic pathology, 24(5), 1996, pp. 531-538
Perbutylated-N-butyl-1-deoxynojiromycin (p-N-butyl-DNJ, SC-49483), an
cr-glucosidase-l inhibitor, is a candidate anti-HIV agent targeted aga
inst viral glycoprotein processing in host cell endoplasmic reticulum.
The potential toxicity of this compound was evaluated in Sprague-Dawl
ey rats after 4, 13, or 26 wk of oral administration at doses ranging
from 300 to 3,670 mg/kg/day. In these studies, the target organs of p-
N-butyl-DNJ effects were thyroid gland, salivary gland, stomach, and p
ancreas. The most prominent histologic change in these organs was the
presence of clear or lightly eosinophilic vacuoles in the cytoplasm of
thyroid follicular cells, gastric chief cells, salivary gland acinar
cells, and exocrine pancreatic acinar cells. Ultrastructurally, these
vacuoles were consistent with dilated rough endoplasmic reticulum, whi
ch sometimes contained homogeneously stained, moderately electron-dens
e material. The vacuoles in thyroid follicular cells contained pale eo
sinophilic colloidlike material consistent with accumulated thyroglobu
lin, as shown by immunohistochemical staining methods. The biological
functions of these organs were not adversely affected as evidenced by
the absence of clinical signs and the results of selected hormonal ana
lyses. The morphologic changes were completely reversed after a 4-wk r
ecovery period. The incidence and severity of histologic changes were
decreased after 13 and 26 wk of treatment compared to 4 wk of treatmen
t, indicating an attenuation of the host response or adaptation to the
prolonged p-N-butyl-DNJ administration. We believe that morphologic c
hanges in thyroid follicular cells, salivary gland acinar cells, pancr
eatic acinar cells, and gastric chief cells were the result of nonspec
ific inhibition of host alpha-glucosidase(s) by p-N-butyl-DNJ, causing
clinically silent perturbation in host cell glycoprotein processing a
nd/or glycoprotein transport.